ReviewAJOG global reports2026
Prevalence of gestational diabetes mellitus in Sub-Saharan Africa: a systematic review and meta-analysis.
Review in AJOG global reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gestational diabetes mellitus (GDM) is a significant cause of adverse perinatal outcomes and major risk factor for type 2 diabetes in mother and child. Although global prevalence is estimated at 14%, the burden in sub-Saharan Africa remains unclear due to limited data and variable diagnostic protocols. This study aimed to generate a robust estimate of GDM prevalence in sub-Saharan Africa using methodologically comparable studies, and to assess subregional variation. Methods: We systematically searched Embase, MEDLINE, CINAHL, Global Health, African Journals Online, and African Index Medicus from January 1990 to March 2025 for observational studies of pregnant women in sub-Saharan Africa screened for GDM at ≥24 weeks' gestation using an oral glucose tolerance test and internationally recognized criteria. Studies using inconsistent, unclear or incomplete diagnostic protocols or self-reported data were excluded. Quality was assessed using the Joanna Briggs Institute checklist. Prevalence estimates were pooled using random-effects meta-analysis of Freeman-Tukey-transformed proportions. Subgroup analyses were conducted by subregion, and mixed-effects meta-regression examined study-level moderators. Findings: Fifty-nine studies met the inclusion criteria, of which 49 were selected for meta-analysis based on use of comparable diagnostic criteria. Studies represented 16 countries and involved 27,540 participants. The pooled GDM prevalence was 14.0% (95% CI, 11.6 to 16.5; prediction interval 1.9 to 34.3) with substantial heterogeneity (I²=97.1%). Prevalence varied across subregions: Southern Africa 10.2%, Eastern Africa 13.9%, Western Africa 15.1%, and Central Africa 18.0%. Meta-regression showed that small studies (<300 participants), studies using point-of-care testing, and studies conducted before 2016 reported higher prevalence. Subregional differences persisted after adjustment. Interpretation: When comparable diagnostic protocols are applied, GDM prevalence in sub-Saharan Africa matches the global average, challenging perceptions of a lower regional burden. Subregional variability highlights the need for locally representative data. Standardized diagnostic criteria for epidemiological studies would improve comparability and inform targeted public health interventions.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.